CDK6 and leukemia: Recent studies have also shown that JAK-STAT signaling pathway genes and CDK6 are downstream targets of NUP98–KDM5A and that NUP98–KDM5A leukemia is vulnerable to JAK or CDK6 inhibition [81,82].